Schrödinger, Inc. (SDGR)

Market Cap	1.37B
Revenue (ttm)	237.92M
Net Income (ttm)	-181.33M
Shares Out	73.61M
EPS (ttm)	-2.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	689,402
Open	18.69
Previous Close	18.78
Day's Range	18.47 - 18.83
52-Week Range	16.60 - 28.47
Beta	1.79
Analysts	Buy
Price Target	28.43 (+53.1%)
Earnings Date	Nov 11, 2025

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 891
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR
• Website: https://www.schrodinger.com

Analyst Summary

According to 7 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price target is $28.43, which is an increase of 53.10% from the latest price.

Price Target

$28.43

(53.10% upside)

Analyst Consensus: Buy